Cargando…

Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis

Background: Attenuated positive psychotic symptoms represent the defining features of the clinical high-risk for psychosis (CHR-P) criteria. The effectiveness of each available treatment for reducing attenuated positive psychotic symptoms remains undetermined. This network meta-analysis (NMA) invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davies, Cathy, Radua, Joaquim, Cipriani, Andrea, Stahl, Daniel, Provenzani, Umberto, McGuire, Philip, Fusar-Poli, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005890/ https://www.ncbi.nlm.nih.gov/pubmed/29946270 http://dx.doi.org/10.3389/fpsyt.2018.00187

Ejemplares similares

Transdiagnostic Individualized Clinically Based Risk Calculator for the Detection of Individuals at Risk and the Prediction of Psychosis: Model Refinement Including Nonlinear Effects of Age
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

Methodological Biases in CBT Trial—Commentary: Modular Cognitive-Behavioral Therapy for Affective Symptoms in Young Individuals at Ultra-High Risk of First Episode of Psychosis: Randomized Controlled Trial
por: Fusar-Poli, Paolo, et al.
Publicado: (2020)

Mapping the implementation and challenges of clinical services for psychosis prevention in England
por: Estradé, Andrés, et al.
Publicado: (2023)

Psychosis Polyrisk Score (PPS) for the Detection of Individuals At-Risk and the Prediction of Their Outcomes
por: Oliver, Dominic, et al.
Publicado: (2019)

Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

M136. PSYCHOSIS POLYRISK SCORE (PPS): IMPROVING DETECTION OF INDIVIDUALS AT-RISK AND PREDICTION OF CLINICAL OUTCOMES
por: Oliver, Dominic, et al.
Publicado: (2020)

DSM-5 Attenuated Psychosis Syndrome in Adolescents Hospitalized With Non-psychotic Psychiatric Disorders
por: Salazar de Pablo, Gonzalo, et al.
Publicado: (2020)

Real World Implementation of a Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk of Psychosis in Clinical Routine: Study Protocol
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

34.2 IMPROVING THE DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS IN SECONDARY MENTAL HEALTH CARE
por: Fusar-poli, Paolo, et al.
Publicado: (2018)

Differences Between Self-Reported Psychotic Experiences, Clinically Relevant Psychotic Experiences, and Attenuated Psychotic Symptoms in the General Population
por: Moriyama, Tais Silveira, et al.
Publicado: (2019)

S149. EFFECTS OF INTRANASAL OXYTOCIN ON RESTING CEREBRAL BLOOD FLOW IN PEOPLE AT ULTRA-HIGH RISK FOR PSYCHOSIS
por: Davies, Cathy, et al.
Publicado: (2018)

Early Intervention Services for First Episode of Psychosis in South London and the Maudsley (SLaM): 20 Years of Care and Research for Young People
por: Fusar-Poli, Paolo, et al.
Publicado: (2020)

New Electronic Health Records Screening Tools to Improve Detection of Emerging Psychosis
por: Fusar-Poli, Paolo
Publicado: (2021)

The Provision of Education and Employment Support At the Outreach and Support in South London (OASIS) Service for People at Clinical High Risk for Psychosis
por: Tognin, Stefania, et al.
Publicado: (2019)

Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk and the Prediction of Psychosis: Second Replication in an Independent National Health Service Trust
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

Transition to psychosis in randomized clinical trials of individuals at clinical high risk of psychosis compared to observational cohorts: a systematic review and meta-analysis
por: Salazar de Pablo, Gonzalo, et al.
Publicado: (2021)

Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study
por: Oliver, Dominic, et al.
Publicado: (2023)

Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study
por: Oliver, Dominic, et al.
Publicado: (2020)

Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis
por: Merritt, Kate, et al.
Publicado: (2013)

Identifying Electroencephalography Biomarkers in Individuals at Clinical High Risk for Psychosis in an International Multi-Site Study
por: Kerins, Sarah, et al.
Publicado: (2022)

Unmet needs for treatment in 102 individuals with brief and limited intermittent psychotic symptoms (BLIPS): implications for current clinical recommendations
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

F256. CAN WE REDUCE THE DURATION OF UNTREATED PSYCHOSIS?
por: Oliver, Dominic, et al.
Publicado: (2018)

Pan-London Network for Psychosis-Prevention (PNP)
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

Physical Health in Clinical High Risk for Psychosis Individuals: A Cross-Sectional Study
por: Provenzani, Umberto, et al.
Publicado: (2023)

Gray Matter Volumetric Abnormalities Associated with the Onset of Psychosis
por: Jung, Wi Hoon, et al.
Publicado: (2012)

Improving the Detection of Individuals at Clinical Risk for Psychosis in the Community, Primary and Secondary Care: An Integrated Evidence-Based Approach
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

Anisotropic Kernels for Coordinate-Based Meta-Analyses of Neuroimaging Studies
por: Radua, Joaquim, et al.
Publicado: (2014)

Examining the variability of neurocognitive functioning in individuals at clinical high risk for psychosis: a meta-analysis
por: Catalan, Ana, et al.
Publicado: (2022)

Can We Reduce the Duration of Untreated Psychosis? A Systematic Review and Meta-Analysis of Controlled Interventional Studies
por: Oliver, Dominic, et al.
Publicado: (2018)

What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors
por: Oliver, Dominic, et al.
Publicado: (2020)

Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use
por: Wiedmann, Melina, et al.
Publicado: (2022)

Diagnostic and Prognostic Significance of Brief Limited Intermittent Psychotic Symptoms (BLIPS) in Individuals at Ultra High Risk
por: Fusar-Poli, Paolo, et al.
Publicado: (2017)

Using Structural Neuroimaging to Make Quantitative Predictions of Symptom Progression in Individuals at Ultra-High Risk for Psychosis
por: Tognin, Stefania, et al.
Publicado: (2014)

Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis
por: Davies, Cathy, et al.
Publicado: (2019)

T122. UNMET NEEDS IN PATIENTS WITH ACUTE TRANSIENT PSYCHOTIC DISORDERS (ATPD): ANALYSIS OF PATHWAYS TO CARE: AN 8 YEARS FOLLOW-UP STUDY
por: Minichino, Amedeo, et al.
Publicado: (2018)

Inequality and barriers in psychosis prevention: A systematic review on clinical high-risk for psychosis studies from developing countries
por: Loch, Alexandre Andrade, et al.
Publicado: (2023)

Timing of antipsychotics and benzodiazepine initiation during a first episode of psychosis impacts clinical outcomes: Electronic health record cohort study
por: Arribas, Maite, et al.
Publicado: (2022)

Psychotic Symptoms Associated With a Frontoparietal Arachnoid Cyst: The Role of Neuroimaging Studies in First-Episode Psychosis
por: Melo, Antonio, et al.
Publicado: (2022)

Basic Self-Disturbances Related to Reduced Anterior Cingulate Volume in Subjects at Ultra-High Risk for Psychosis
por: Bonoldi, Ilaria, et al.
Publicado: (2019)

Perceived Family Functioning Profile in Adolescents at Clinical High Risk for Psychosis: Rigidity as a Possible Preventive Target
por: Iorio, Melanie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bpgbf78qqmohd0m00soc2bv29d